Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Renren Inc (RENN): Wall Street’s Wrong About, Inc. (ADR) (BIDU)

It’s clear who the market thought was the big winner in Renren Inc (NYSE:RENN)‘s deal to sell a majority stake in its Nuomi group-buying site to, Inc. (ADR) (NASDAQ:BIDU) on Friday. Shares of Renren moved 5% higher after Baidu agreed to pay $160 million for a 59% stake in Nuomi, while Baidu’s stock slipped 1%., Inc. (ADR) (NASDAQ:BIDU)

There’s cruel math behind knee-jerk reactions., Inc. (ADR) (NASDAQ:BIDU)’s market cap shed more than $300 million in value on Friday — and probably more on a relative basis, since the Nasdaq moved nicely higher that day. Why should, Inc. (ADR) (NASDAQ:BIDU) be marked down by roughly double the value of its investment? Nuomi isn’t that bad.

Groupon Inc (NASDAQ:GRPN) may have dimmed the market’s optimism for daily-deals providers, but even the bellwether has been clawing its way out of the doghouse lately. Groupon Inc (NASDAQ:GRPN) shares have more than doubled in 2013.

Nuomi is still a small player in China. It generated $120 million in general merchandise sales in its latest quarter, which resulted in just $6.2 million in revenue for Renren Inc (NYSE:RENN)– but Nuomi did have 3.8 million active paying customers, 44% ahead of where it was a year earlier. At least its popularity is moving in the right direction., Inc. (ADR) (NASDAQ:BIDU) also points out that 30% of Nuomi’s purchases came from mobile devices. That’s important, especially for China’s leading search engine., Inc. (ADR) (NASDAQ:BIDU) rallied earlier this month, after it acquired China’s leading mobile apps marketplace operator in a $1.9 billion buyout. The market ate that deal up, since the market was growing worried about, Inc. (ADR) (NASDAQ:BIDU)’s ability to embrace the migration from desktop search to mobile gadgetry.

In the end, Friday’s sell-off was an overreaction, and not just because Baidu’s market cap assumes that Nuomi is worth less than worthless. It’s not. One of the reasons for Renren Inc (NYSE:RENN)’s pop is that is still retains 41% of the group-buying subsidiary that should become even more prolific under Baidu’s watch. There will be increased visibility through Baidu’s audience, and that’s going to make this a good deal for both the buyer and the seller.

Baidu also had more than $5.5 billion in cash and marketable securities sitting on its balance sheet at the end of June. Are Friday’s sellers really going to argue that Baidu needed that $160 million or that it was going to be more productive parked in Baidu’s substantial vault of money?

Baidu and Renren did a smart thing on Friday. The market reaction only got half of that right.

The article Wall Street’s Wrong About Baidu originally appeared on is written by Rick Munarriz.

Longtime Fool contributor Rick Munarriz has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Baidu.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.